With the implementation of documents such as consistency evaluation, "two-vote system", VAT reform, and the normalization of "4+7" procurement with quantity, traditional pharmaceutical marketing is gradually difficult
.
It is worth noting that in this context, digitalization has increasingly become an emerging force for the transformation and upgrading of China's medical system, and the integration and innovation of the pharmaceutical industry has begun to become a new trend
in the current industry.
Recently, Shanghai Qingyun Pharmaceutical Technology Co.
, Ltd.
announced the completion of a new round of financing
of tens of millions of dollars.
It is understood that this round of funds will further accelerate the application upgrade and functional innovation of Qingyun Technology's self-developed AI digital marketing platform, and improve the layout of the grass-roots market omni-channel marketing network with the county as the core
.
Through high-quality and efficient marketing data, marketing tools and marketing services, we help the development and transformation
of digital marketing of pharmaceutical enterprises.
In September, at the 2022 Digital Pharmaceutical Industry Forum and the 6th Anniversary of Alibaba Health Pharmacy, Alibaba Health also released a global digital marketing model and several major trends of OTC marketing, starting from the logic of content growth in the pharmaceutical industry to help pharmaceutical brands find sustainable value space
in the off-campus market.
In March, Merck underwent a restructuring in China, creating two new roles as Data Protection Officer and Chief Transformation Officer, and merging the Digital Interaction and Transformation and Commercial Operations divisions, establishing a new division for business excellence, merging commercial operations and key account management departments, and establishing a new division for commercial excellence.
.
.
Industry analysts believe that with more and more international pharmaceutical companies deeply cultivating the Chinese market and the rise of domestic pharmaceutical companies, how to explore the digital marketing methodology of medicine, how to grasp policy opportunities and user needs, and use digitalization to promote pharmaceutical innovation marketing has become the focus of
attention in the industry.
In fact, from the current point of view, digitalization has become a trend in the development of the pharmaceutical industry, in addition to bringing new technical means and development opportunities for sales, etc.
, in fact, it is also playing an increasingly important role
in research and development, production and other aspects.
For example, in recent years, under the background of the country and even the local efforts to empower the traditional Chinese medicine industry through digitalization, traditional Chinese medicine scientific research has gradually achieved good results
in innovation.
Taking Tasly as an example, in view of the digital and intelligent research and development of traditional Chinese medicine, it has built an artificial intelligence big data platform with independent intellectual property rights, which has promoted the leapfrog development of traditional Chinese medicine to digital Chinese medicine research and development
.
At present, the platform has successfully accumulated 60T of massive characteristic pharmaceutical data resources, built multiple databases covering multiple omics of diseases, Chinese herbal medicine-ingredients-targets, and small molecules of drugs, and built more than 30 analysis pipelines such as AI disease networks, biomedical knowledge graphs, and drug relocation
.
In general, with the help of the Internet, it has become an industry consensus
to seize digitalization to achieve transformation and upgrading.
After all, the commercialization pressure brought about by high R&D costs is forcing many pharmaceutical companies to accelerate R&D through digitalization, as well as make breakthroughs in the out-of-hospital market, shorten the time period for products to reach the market, improve the awareness rate of new products, and cover more patients
.
The industry expects that in the future, with the further deepening of the reform of the pharmaceutical system, the development of pharmaceutical enterprises in digitalization will continue to accelerate
.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize:"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)];
